POSEIDON Study of Dual Immunotherapy Regimens in Advanced NSCLC

Melissa Johnson, MD, explains the design and outcomes of the multi-arm POSEIDON study, which featured a combination of 4 agents for the treatment of advanced NSCLC.

Related Videos
View All
Related Content